Chesnara Plc: Fourth acquisition in two years
12 November 2026
Investors in the healthcare sector should pay close attention to iRhythm Holdings, Inc. (NASDAQ: IRTC), a company at the forefront of digital healthcare innovation. With a..
Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the biotechnology sector, continues to capture investor interest with a compelling potential upside of 31.92%. Headquartered in..
CVS Health Corporation (NYSE: CVS) presents a compelling case for investors seeking a balanced opportunity in the healthcare sector. With a market capitalization of $99.84 billion,..
Elevance Health, Inc. (NYSE: ELV), once known as Anthem, Inc., stands as a behemoth in the healthcare industry with a market capitalization of $76.54 billion. The..
In the dynamic world of biotechnology, Telix Pharmaceuticals Limited (ASX: TLX) stands out as a compelling investment opportunity. With a remarkable potential upside of 235%, this..
Tempus AI, Inc. (NASDAQ: TEM) is rapidly emerging as a compelling player in the healthcare technology sector, specifically within the health information services industry. With a..
Revolution Medicines, Inc. (NASDAQ: RVMD) is capturing investor attention with its innovative approach to treating RAS-addicted cancers and its enticing potential upside of 26.62%. As a..
Option Care Health, Inc. (NASDAQ: OPCH) has positioned itself as a key player in the healthcare sector, specifically within the medical care facilities industry. Headquartered in..
Stevanato Group S.p.A. (NYSE: STVN), a prominent player in the healthcare sector, is capturing investor attention with its robust growth trajectory and substantial upside potential. With..
Guardant Health, Inc. (GH) is making waves in the healthcare sector with its innovative approach to diagnostics and research. As a leader in precision oncology, the..
BridgeBio Pharma, Inc. (NASDAQ: BBIO) is carving a niche in the biotechnology sector with a focus on developing therapeutics for genetic diseases and cancers. Based in..
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is catching the attention of investors with an enticing potential upside of 44.41%. As a prominent player in the biotechnology industry,..
Axsome Therapeutics, Inc. (NASDAQ: AXSM) has become a prominent player in the biotechnology sector, focusing on novel therapies for central nervous system (CNS) disorders. With a..
ADMA Biologics Inc (NASDAQ: ADMA) stands as a compelling opportunity in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $3.84 billion,..
AstraZeneca PLC (NASDAQ: AZN), a stalwart in the healthcare sector, has captured the attention of investors worldwide. With a market capitalization of $318.66 billion, this UK-based..
Nuvalent, Inc. (NASDAQ: NUVL), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its innovative approach to treating cancer. With a market capitalization..
Ascendis Pharma A/S (NASDAQ: ASND) is making waves in the biotechnology sector with its innovative TransCon-based therapies, capturing the attention of investors seeking growth in the..
Smith & Nephew SNATS, Inc. (NYSE: SNN) is a prominent entity in the healthcare sector, specifically within the medical devices industry. With a market capitalization of..
TG Therapeutics, Inc. (NASDAQ: TGTX) stands as a compelling player in the biotechnology sector, particularly for investors keen on the healthcare industry. With a market capitalization..
Vaxcyte, Inc. (NASDAQ: PCVX) is catching the attention of investors with its potential for significant upside, estimated at an impressive 88.75%. As a clinical-stage company making..
